Neurobiology of marijuana abuse - PubMed (original) (raw)

Review

Neurobiology of marijuana abuse

M E Abood et al. Trends Pharmacol Sci. 1992 May.

Abstract

Marijuana has a long history of abuse yet, as described here by Mary Abood and Billy Martin, there is little evidence that animals will self-administer the primary psychoactive constituent, tetrahydrocannabinol, or that marijuana stimulates brain reward pathways. While marked tolerance develops to marijuana, it has been difficult to demonstrate physical dependence, and until recently the mechanisms by which cannabinoids produced their behavioral effects were poorly defined. The development of new synthetic analogs played a critical role in the characterization and cloning of the cannabinoid receptor. Insight into cannabinoid receptors may lead to a better understanding of marijuana abuse in humans and provide new therapeutic strategies for several disorders.

PubMed Disclaimer

Similar articles

• Neurobiology of cocaine abuse.
  Woolverton WL, Johnson KM. Woolverton WL, et al. Trends Pharmacol Sci. 1992 May;13(5):193-200. doi: 10.1016/0165-6147(92)90063-c. Trends Pharmacol Sci. 1992. PMID: 1604712 Review.
• Cannabinoids: reward, dependence, and underlying neurochemical mechanisms--a review of recent preclinical data.
  Tanda G, Goldberg SR. Tanda G, et al. Psychopharmacology (Berl). 2003 Sep;169(2):115-34. doi: 10.1007/s00213-003-1485-z. Epub 2003 Jun 24. Psychopharmacology (Berl). 2003. PMID: 12827346 Review.
• Cannabis: pharmacology and toxicology in animals and humans.
  Adams IB, Martin BR. Adams IB, et al. Addiction. 1996 Nov;91(11):1585-614. Addiction. 1996. PMID: 8972919 Review.
• Neurobiology of alcohol abuse.
  Samson HH, Harris RA. Samson HH, et al. Trends Pharmacol Sci. 1992 May;13(5):206-11. doi: 10.1016/0165-6147(92)90065-e. Trends Pharmacol Sci. 1992. PMID: 1306042 Review.
• Neurobiology of cannabis addiction.
  Jain R, Balhara YP. Jain R, et al. Indian J Physiol Pharmacol. 2008 Jul-Sep;52(3):217-32. Indian J Physiol Pharmacol. 2008. PMID: 19552052 Review.

Cited by

• Chain Substituted Cannabilactones with Selectivity for the CB2 Cannabinoid Receptor.
  Alapafuja SO, Nikas SP, Ho TC, Tong F, Benchama O, Makriyannis A. Alapafuja SO, et al. Molecules. 2019 Oct 1;24(19):3559. doi: 10.3390/molecules24193559. Molecules. 2019. PMID: 31581433 Free PMC article.
• Chronic cannabis smoking-enriched oral pathobiont drives behavioral changes, macrophage infiltration, and increases β-amyloid protein production in the brain.
  Luo Z, Fitting S, Robinson C, Benitez A, Li M, Wu Y, Fu X, Amato D, Ning W, Funderburg N, Wang X, Zhou Z, Yu X, Wagner A, Cong X, Xu W, Maas K, Wolf BJ, Huang L, Yu J, Scott A, Mcrae-Clark A, Hamlett ED, Jiang W. Luo Z, et al. EBioMedicine. 2021 Dec;74:103701. doi: 10.1016/j.ebiom.2021.103701. Epub 2021 Nov 23. EBioMedicine. 2021. PMID: 34826801 Free PMC article.
• Functional tolerance and blockade of long-term depression at synapses in the nucleus accumbens after chronic cannabinoid exposure.
  Hoffman AF, Oz M, Caulder T, Lupica CR. Hoffman AF, et al. J Neurosci. 2003 Jun 15;23(12):4815-20. doi: 10.1523/JNEUROSCI.23-12-04815.2003. J Neurosci. 2003. PMID: 12832502 Free PMC article.
• Hippocampal neurotoxicity of Delta9-tetrahydrocannabinol.
  Chan GC, Hinds TR, Impey S, Storm DR. Chan GC, et al. J Neurosci. 1998 Jul 15;18(14):5322-32. doi: 10.1523/JNEUROSCI.18-14-05322.1998. J Neurosci. 1998. PMID: 9651215 Free PMC article.

Publication types

MeSH terms

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Medical

  • MedlinePlus Consumer Health Information
  • MedlinePlus Health Information

• Molecular Biology Databases

  • Guide to Pharmacology